|
Market Report
|
Global Ophthalmology Devices Market
Global ophthalmology devices and drugs market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
|
|
Read more...
|
|
|
Market Report
|
Nonalcoholic Steatohepatitis - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData, the industry analysis specialist's new report, "Nonalcoholic Steatohepatitis (NASH) - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global nonalcoholic steatohepatitis market. The report identifies the key trends shaping and driving the global nonalcoholic steatohepatitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global nonalcoholic steatohepatitis sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.
|
|
Read more...
|
|
|
Market Report
|
HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData's report, "HIV/AIDS - Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global HIV/AIDS market. The report identifies the key trends shaping and driving the global HIV/AIDS market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders.
|
|
Read more...
|
|
|
Market Report
|
|
Diagnostic ECG Market (2009 - 2014)
The global diagnostic ECG market is categorized into three submarkets: the rest systems the stress systems and holter systems. These systems are used to measure the electrical activity of the heart. Amongst the three systems, rest system is the most widely-used diagnostic tool. The global market for rest system is expected to grow at a CARG of 9.6% from 2009 to 2014.
|
|
Read more...
|
|
|
Market Report
|
In-Vitro Diagnostics (IVD) Market in BRIC (2010 - 2014)
The IVD markets of BRIC economies offer immense growth opportunities due to the increasing healthcare budgets in these nations, along with the increasing number of private corporate hospitals, and the rising income levels backed by a huge, untapped population bases.
|
|
Read more...
|
|
|
Market Report
|
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
Drug delivery can play an important role at all stages of a drug's lifecycle and has become an ever present feature in the business model of the leading pharmaceutical companies. Using the PharmaVitae Explorer database, the report provides an in depth sales analysis of the specific routes of administration driving the pharmaceutical market out to 2014.
|
|
Read more...
|
|
|
Market Report
|
Pharmaceutical Key Trends 2010 - The patent cliff dominates but growth opportunities remain
Pharma faces a number of key resistors to growth including the impending 2011 patent cliff which is set to erode $78 billion in global branded sales from drugs facing patent expiry over the 2010/14 period (plus $32 billion from continued erosion of already expired brands). Price cuts, reimbursement restrictions and growing regulatory pressure are further set to limit sales growth going forward.
|
|
Read more...
|
|
|
Market Report
|
U.S. Preterm Infant Care Market
Preterm infant care forms a significant part of the pediatric healthcare market in the U.S. as preterm births are one of the leading causes of infant mortality in the country. One in every eight births in the U.S. are preterm, and the condition is on an alarming rise due to factors such as induced fertility, labor treatments, poor prenatal care, inappropriate maternal age, obesity, and smoking.
|
|
Read more...
|
|
|
Market Report
|
Disease Modification in Rheumatoid Arthritis - Anti-TNFs defend first-line biologic position despite competition
Datamonitor forecasts that total sales for the seven major rheumatoid arthritis markets will grow from $7 billion in 2007 to over $12 billion in 2017. The sustained uptake of anti-TNFs combined with the launch of several new biologic products will drive growth in the short-and mid-term. However, biosimilar entry will cause a small contraction in market value at the end of the forecast period.
|
|
Read more...
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
|
| Results 28 - 36 of 366 |
Farmavita.Net Journal 
